Lisa Kammerman, PhD is a Senior Statistical Director in Oncology at AstraZeneca. She consults on PRO projects and regulatory submissions. She developed AZ's PRO guidance document and led AZ's missing data project. After 24 years of public service, she retired from the FDA, where she led the Office of Biostatistics’ Clinical Outcome Assessments program. In that role, she helped develop policy for the design, analysis, and interpretation of studies that use Clinical Outcome Assessments.